NEW YORK (GenomeWeb News) – Decode Genetics said today that it has received a delisting notice from Nasdaq following the firm's announcement last week that it has filed for Chapter 11 bankruptcy protection.

Nasdaq informed Decode that it will suspend trading in the company’s common stock as of Nov. 30, 2009, and that it will file a Form 25-NSE with the US Securities and Exchange Commission to remove Decode's common stock from listing on Nasdaq, unless the company files an appeal to the Nasdaq Listing Qualifications Panel.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.